FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

634211000001100: Oruvail 2.5% gel (Aventis Pharma) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17431701000001110 Oruvail 2.5% gel (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65917401000001113 Oruvail 2.5% gel (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oruvail 2.5% gel (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Is a Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has excipient Fragrances false Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has active ingredient Ketoprofen false Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Is a Oruvail true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has specific active ingredient Ketoprofen true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Oruvail 2.5% gel (Aventis Pharma) 30 gram Is pack of False Oruvail 2.5% gel (Aventis Pharma) Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) 100 gram Is pack of False Oruvail 2.5% gel (Aventis Pharma) Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) 30 gram Has AMP True Oruvail 2.5% gel (Aventis Pharma) Inferred relationship Existential restriction modifier
Oruvail 2.5% gel (Aventis Pharma) 100 gram Has AMP True Oruvail 2.5% gel (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start